COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 1497: Articles 14961-14970  | Next

COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma
Ramasamy, K., Sadler, R., Jeans, S., Varghese, S., Turner, A., Larham, J., Gray, N., Barrett, J., Bowcock, S., Cook, G., Kyriakou, C., Smith, D., Drayson, M., Basu, S., Moore, S., McDonald, S., Gooding, S., Javaid, M. K.
10.1101/2021.05.20.21257379 — Posted: 2021-05-22
Assessing the Impact of Human Mobility to Predict Regional Excess Death in Ecuador
Cuellar, L., Torres, I., Romero-Severson, E. O., Mahesh, R., Ortega, N., Pungitore, S., Ke, R., Hengartner, N.
10.1101/2021.05.19.21257056 — Posted: 2021-05-22
Reactogenicity of homologous and heterologous prime-boost immunization with BNT162b2 and ChAdOx1-nCoV19: a prospective cohort study
Hillus, D., Tober-Lau, P., Hastor, H., Helbig, E. T., Lippert, L. J., Thibeault, C., Solarek, A., Kalle, C. v., Corman, V. M., Kopankiewicz, P., Suttorp, N., Bias, H., Seybold, J., Kurth, F., Sander, L. E.
10.1101/2021.05.19.21257334 — Posted: 2021-05-22 Discussion: Offsite
Evaluation of a Rapid Implementation of Telemedicine for Delivery of Obstetric Care During the COVID-19 Pandemic
Reid, C., Marshall, J., Fryer, K.
10.1101/2021.05.19.21257311 — Posted: 2021-05-22
Public Health and Health Systems Impacts of SARS-CoV-2 Variants of Concern: A Rapid Scoping Review
Curran, J. A., Dol, J., Boulos, L., Somerville, M., Reynolds, B., Gallant, A., Saxinger, L., Doroshenko, A., Shin, D., Wong, H., Crowther, D., MacDonald, M., Martin-Misener, R., Hayden, J., Comeau, J., McCulloch, H.
10.1101/2021.05.20.21257517 — Posted: 2021-05-22
The risk of SARS-CoV-2 outbreaks in low prevalence settings following the removal of travel restrictions
Sachak-Patwa, R., Byrne, H. M., Dyson, L., Thompson, R. N.
10.1101/2021.05.21.21257589 — Posted: 2021-05-22
Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2
Parvu, V., Gary, D., Mann, J., Lin, Y.-C., Mills, D., Cooper, L., Andrews, J. C., Manabe, Y., Pekosz, A., Cooper, C. K.
10.1101/2021.05.20.21257181 — Posted: 2021-05-22
A Deep Recurrent Reinforced Learning model to compare the efficacy of targeted local vs. national measures on the spread of COVID-19 in the UK
Dong, T., benedetto, u., Sinha, S., Dimagli, A., Caputo, M., Angelini, G. D.
10.1101/2021.05.21.20248630 — Posted: 2021-05-22 Discussion: Onsite
Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo
Almanza-Reyes, H., Moreno, S., Plascencia-Lopez, I., Alvarado-Vera, M., Patron-Romero, L., Borrego, B., Reyes-Escamilla, A., Valencia-Manzo, D., Brun, A., Pestryakov, A., Bogdanchikova, N.
10.1101/2021.05.20.21256197 — Posted: 2021-05-22
Mechanistic model calibration and the dynamics of the COVID-19 epidemic in the UK (the past, the present and the future)
Willis, M. J., Wright, A., Bramfitt, V., Conn, H., Talyor, R.
10.1101/2021.05.18.21257384 — Posted: 2021-05-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).